A prospective study of minimally invasive techniques in pediatric surgical oncology: preliminary report
✍ Scribed by Warmann, Steven ;Fuchs, J�rg ;Jesch, Nathalie K. ;Schrappe, Martin ;Ure, Benno M.
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 56 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Thoracoscopic and laparoscopic techniques play a major role in pediatric surgery. However, minimally invasive surgery (MIS) has not yet established itself in pediatric surgical oncology. The authors present a prospective study investigating the role of MIS in children with cancer.
Procedure
All children with abdominal or thoracic tumors requiring surgery were registered between September, 2000 and February, 2002. Decisions regarding procedures and approaches—conventional or minimally invasive—were made by the interdisciplinary team. Data on diagnoses, surgical procedures, complications, and conversion rates were registered prospectively.
Results
Seventy‐four patients received 78 operations, 21 (26.9%) of the 78 operations were minimally invasive. Seven of 16 tumor biopsies (43.8%) and 9 of 57 tumor resections (15.8%) were performed using MIS, which was also exclusively used for diagnostic interventions. Conversions to standard techniques only occurred in 5 of 9 tumor resections. No major complications were encountered in the MIS group.
Conclusions
MIS was practical in every fourth patient in our experience so far. It proved to be an excellent approach in diagnostic interventions and tumor biopsies, whereas efficacy is limited in tumor resections. Further factors (tumor recurrence, trocar site recurrence, tumor growth, and dissemination after CO~2~ insufflation) have to be evaluated. Our data encourage the continuation of the study. Med Pediatr Oncol 2003;40:155–157. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Forty‐two evaluable pediatric patients with a variety of recurrent primary brain tumors participated in a phase II ifosfamide trial. Their mean age was 10 years. All patients were treated with ifosfamide, 3 g/m^2^/day for 2 days every 2 weeks. Response was assessed on clinical and radio
This work has been previously presented as communication at the following meetings: International Society of Pediatric Oncology (SIOP) 26th Annual Meeting, Paris, France, September BACKGROUND. Neuroblastoma is the most common malignant cause of spinal compression in the pediatric population. More th
A retrospective review of the Eastern Cooperative Oncology Group adjuvant chemotherapy studies EST 5177 and EST 6177 was performed in order to ascertain the first indicator of relapse in women with breast cancer and pathologically positive axillary lymph nodes. Of 856 evaluable patients, 208 have re